Tuberculosis in the elderly: Keep a high index of suspicion

Journal of Respiratory Diseases

Volumn 27, Issue 7, 2006, Pages 307-315

  Chmura, Kathryn ^a   Chan, Edward D ^a  

^a Department of Medicine ^*

Author keywords

Geriatrics; Tuberculosis

Indexed keywords

AMIKACIN; AZITHROMYCIN; BUSPIRONE; CAPREOMYCIN; CIMETIDINE; CLARITHROMYCIN; CLOZAPINE; CYCLOSPORIN; DIGOXIN; DOXYCYCLINE; ETHAMBUTOL; FLUCONAZOLE; ISONIAZID; KANAMYCIN; KETOCONAZOLE; MIDAZOLAM; OFLOXACIN; PHENYTOIN; PROPAFENONE; PROTEIN DERIVATIVE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SERTRALINE; SIMVASTATIN; STREPTOMYCIN; SULFONYLUREA; TACROLIMUS; THYROXINE; UNINDEXED DRUG;

ACID FAST BACTERIUM; AGED; ANEMIA; ANTIBIOTIC PROPHYLAXIS; BACTERIUM CULTURE; COUGHING; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG METABOLISM; FEMALE; FEVER; HEMOPTYSIS; HEPATOSPLENOMEGALY; HUMAN; LIVER DISEASE; LIVER FUNCTION; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NONHUMAN; PNEUMONIA; PROTEIN PURIFICATION; REVIEW; SMEAR; SPUTUM CULTURE; TUBERCULOSIS;

EID: 33750297557     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Stead WW. Tuberculosis among elderly persons: an outbreak in a nursing home. Ann Intern Med. 1981;94:606-610.
2. Stead WW, Lofgren JR, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med. 1985;312:1483-1487.
3. Powell KE, Farer LS. The rising age of the tuberculosis patient: a sign of success and failure. J Infect Dis. 1980;142:946-948.
4. Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest. 1987;92:237-240.
5. Dutt AK, Stead WW. Tuberculosis in the elderly. Med Clin North Am. 1993;77:1353-1368.
6. Tocque K, Bellis MA, Tam CM, et al. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med. 1998;158:484-488.
7. Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis. 1967;95:729-745.
8. Yoshikawa TT. Tuberculosis in aging adults. J Am Geriatr Soc. 1992;40:178-187.
9. Dutt AK, Stead WW. Tuberculosis. Clin Geriatr Med. 1992;8:761-775.
10. Stead WW. Why does tuberculosis remain so common among the elderly? Hosp Pract (Off Ed). 1987;22:9,13.
11. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N. Mortality among tuberculosis patients in The Netherlands in the period 1993-1995. Eur Respir J. 1998;11:816-820.
12. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
13. Corberand J, Ngyen F, Laharrague P, et al. Polymorphonuclear.functions and aging in humans. J Am Geriair Soc. 1981;29:391-397.
14. Schwab R, Walters CA, Weksler ME. Host defense mechanisms and aging. Semin Oncol. 1989;16:20-27.
15. Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev. 2005;205:229-243.
16. Orme IM. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol. 1987;138:4414-4418.
17. Turner J, Frank AA, Orme IM. Old mice express a transient earty resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect Immun. 2002;70:4628-4637.
18. Orme IM, Griffin JP, Roberts AD, Ernst DN. Evidence for a defective accumulation of protective T cells in old mice infected win Mycobacterium tuberculosis. Cell Immunol. 1993;147:222-229.
19. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol. 1987;138:292-298.
20. Cooper AM, Callahan JE, Griffin JP, et al. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immun. 1995;63:3259-3265.
21. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun. 1999;67:3980-3988.
22. Turner J, D'Souza CD, Pearl JE, et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol. 2001;24:203-209.
23. Mogues T, Goodrich ME, Ryan L, et al. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycooacferium tuberculosis infection in mice. J Exp Med. 2001;193:271-280.
24. Turner J, Orme IM. The expression of early resistance to an infection with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-gamma) but not IFN type I. Mech Ageing Dev. 2004;125:1-9.
25. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med. 1987;107:837-842.
26. Welty C, Burstin S, Muspratt S, Tager IB. Epidemiology of tuberculous infection in a chronic care population. Am Rev Respir Dis. 1985;132:133-136.
27. Alvarez S, Kasprzyk OR, Freundl M. Two-stage skin testing for tuberculosis in a domiciliary population. Am Rev Respir Dis. 1987;136:1193-1196.
28. Van den Brande P, Demedts M. Four-stage tuberculin testing in elderly subjects induces age-dependent progressive boosting. Chest. 1992;101:447-450.
29. Thompson NJ, Glassroth JL, Snider DE Jr, Farer LS. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis. 1979;119:587-597.
30. Perez-Stable EJ, Flaherty D, Schecter G, et al. Conversion and reversion of tuberculin reactions in nursing home residents. Am Rev Respir Dis. 1988;137:801-804.
31. Fullerton JM, Dyer L. Unsuspected tuberculosis in the aged. Tubercle. 1965;46:193-198.
32. King D, Davies PO. Disseminated tuberculosis in the elderly: still a diagnosis overlooked. J R Soc Med. 1992;85:48-50.
33. Mackay AD, Cole RB. The problems of tuberculosis in the elderly. Q J Med. 1984;53:497-510.
34. Morris CD. The radiography, haematology and biochemistry of pulmonary tuberculosis in the aged. Q J Med. 1989;71:529-536.
35. Morris CD, Pulmonary tuberculosis in the elderly: a different disease? Thorax. 1990;45:912-913.
36. Nagami PH, Yoshikawa TT. Tuberculosis in the geriatric patient. J Am Geriair Soc. 1983;31:356-363.
37. Teale C, Goldman JM, Pearson SB. The association of age with the presentation and outcome of tuberculosis: a five-year survey. Age Ageing. 1993;22:289-293.
38. Alvarez S, Shell C, Berk SL. Pulmonary tuberculosis in elderly men. Am J Med. 1987;82:602-606.
39. Katz PR, Reichman W, Dube D, Feather J. Clinical features of pulmonary tuberculosis in young and old veterans. J Am Geriatr Soc. 1987;35:512-515.
40. Umeki S. Comparison of younger and elderly patients with pulmonary tuberculosis. Respiration. 1989;55:75-83.
41. Van den Brande P, Vijgen J, Demedts M. Clinical spectrum of pulmonary tuberculosis in older patients: comparison with younger patients. J Gerontot. 1991;46:M204-M209.
42. Fulton JD, McCallion J. Tuberculosis-diagnostic difficulty in the elderly. J Clin Exp Gerontol. 1987;9:303-311.
43. Korzeniewska-Kosela M, Krysl J, Muller N, et al. Tuberculosis in young adults and the elderly. A prospective comparison study. Chest. 1994;106:28-32.
44. Perez-Guzman C, vargas MH, Torres-Cruz A, Villarreal-velarde H. Does aging modify pulmonary tuberculosis?: A meta-analytical review. Chest. 1999;116:961-967.
45. Van den Brande P, Vernies T, Verwerft J, et al. Impact of age and radiographic presentation on the presumptive diagnosis of pulmonary tuberculosis. Respir Med. 2002;96:979-983.
46. Patel YR, Mehta JB, Harvill L, Gateley K. Flexible bronchoscopy as a diagnostic tool in the evaluation of pulmonary tuberculosis in an elderly population. J Am Geriatr Soc. 1993;41:629-632.
47. Stead WW, To T, Harrison RW, Abraham JH 3rd. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med. 1987;107:843-845.
48. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Res Crit Care Med. 2000;161(suppl):S221- S247.
49. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public heatth tuberculosis clinic. JAMA. 1999;281:1014-1018.
50. Chan ED, Chmura K. Diagnosis and treatment of latent tuberculosis infection. J Clin Outcomes Manage, 2004;11:182-187.
51. Hong Kong Chest Service and British Medical Research Council: A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis. 1992;145:36-41.
52. Ridzon R, Meador J, Maxwell R, et al. Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin. Clin Infect Dis. 1997;24:1264-1265.
53. Hom DL, Hewlett D Jr, Alfalla C, et al. Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis. N Engl J Med. 1994;330:1241.
54. Vlllarino ME, Dooley SW, Geiter LJ, et al. Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41(RR-11):61-71.
55. Chaulk CP, Pope DS. The Baltimore City Department program of directly observed therapy for tuberculosis. Clin Chest Med. 1997;18:149-154.
56. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003;48;133-143.
57. Finch CK, Chrisman CR, Baciewicz AM, Self TH. Rifampin and rifabutin drug interactions: an update. Arch Intern Med. 2002;162:985-992.
58. Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med. 1995;26:43-52.
59. Pande JN, Singh SP, Khilnani GC, et al. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. Thorax. 1996;51:132-136.
60. Sharma SK, Balamurugan A, Sana PK, et al. Evaluation of conical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med. 2002;166:916-919.
61. Chan ED, Chatterjee D, Iseman MD, Heifets LB. Pyrazinamide, ethambutol, ethionamide, and aminoglycosides. In: Rom WM, Garay SM, eds. Tuberculosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:773-789.
62. Varughese A, Brater DC, Benet LZ, Lee CS. Ethambutol kinetics in patients with impaired renal function. Am Rev Respir Dis. 1986;134:34-38.
63. Iseman MD. Mycobacterium avium complex and the normal host: the other side of the coin. N Engl J Med. 1989:321:896-898.
64. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 1991;144:914-916.
65. Kennedy TP, Weber DJ. Nontuberculous mycobacteria. An underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med. 1994;149:1654-1658.
66. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321:863-868.
67. Davidson PT, Khanijo V, Goble M, Moulding TS. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis. 1981;3:1052-1059.